Vitamin A and D supplements after stem cell transplant
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests whether taking vitamin A and D after a stem cell transplant can help improve recovery. It is for people with certain blood cancers who have a matched donor and are in remission or have low disease activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer like acute leukemia, myelodysplastic syndrome, or multiple myeloma.
- Your disease is in remission or mostly controlled (few cancer cells in bone marrow or blood).
- You have a related or unrelated donor with a good HLA match (10/10 or 9-10/10).
- You are 18 years or older and generally healthy without major organ problems.
- You have not had a prior stem cell transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a stronger chemo and radiation plan before a stem cell transplant for people with myelodysplastic syndrome (a blood disorder) or acute myeloid leukemia (a blood cancer). The goal is to help the transplant work better and reduce the chance of the disease coming back.
This study tests whether giving a drug called VA (which includes a vitamin A derivative and a medication that helps the immune system fight cancer) after a stem cell transplant can help keep leukemia or MDS from coming back. It is for patients who are already in remission after their transplant.
This trial tests a combination of four medicines (cyclophosphamide, abatacept, vedolizumab, and ruxolitinib) to prevent graft-versus-host disease (GVHD) after a stem cell transplant for children and young adults with certain blood cancers. The goal is to see if this approach reduces the risk of GVHD, a serious complication where donor cells attack the body.
This study tests whether giving extra immune cells (called DLI) before or after a stem cell transplant can help prevent or treat leukemia relapse. These cells come from the same family member who donated your transplant, and the study also asks the donor to do some exercise sessions beforehand.
This trial tests a combination of three drugs (vedolizumab, cyclophosphamide, and tacrolimus) to prevent graft-versus-host disease, a common complication after a donor stem cell transplant. It is for people with certain blood cancers who are getting a reduced-intensity transplant.
This study tests a new way to reduce donor-specific antibodies before a stem cell transplant. It combines standard treatments with an increased infusion of donor cells to help improve transplant success.
Hear when a new Acute Lymphoblastic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.